^
Association details:
Biomarker:No biomarker
Cancer:Endometrial Cancer
Drug:Torisel (temsirolimus) (mTOR inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
...the NCCN panel considers bevacizumab or temsirolimus as appropriate single-agent biologic therapy for patients who have progressed on previous cytotoxic chemotherapy.